key: cord-0949471-3wqiigv9 authors: Sammour, Yasser; Spertus, John A.; Austin, Bethany A.; Magalski, Anthony; Gupta, Sanjaya K.; Shatla, Islam; Dean, Evelyn; Kennedy, Kevin F.; Jones, Philip G.; Nassif, Michael E.; Main, Michael L.; Sperry, Brett W. title: Outpatient Management of Heart Failure During the COVID-19 Pandemic After Adoption of a Telehealth Model date: 2021-10-06 journal: JACC Heart Fail DOI: 10.1016/j.jchf.2021.07.003 sha: 1658b97db6160f297fed5d35346442f8a1472e55 doc_id: 949471 cord_uid: 3wqiigv9 OBJECTIVES: This study sought to determine whether the increased use of telehealth was associated with a difference in outcomes for outpatients with heart failure. BACKGROUND: The COVID-19 pandemic led to dramatic changes in the delivery of outpatient care. It is unclear whether increased use of telehealth affected outcomes for outpatients with heart failure. METHODS: In March 2020, a large Midwestern health care system, encompassing 16 cardiology clinics, 16 emergency departments, and 12 hospitals, initiated a telehealth-based model for outpatient care in the setting of the COVID-19 pandemic. A propensity-matched analysis was performed to compare outcomes between outpatients seen in-person in 2018 and 2019 and via telemedicine in 2020. RESULTS: Among 8,263 unique patients with heart failure with 15,421 clinic visits seen from March 15 to June 15, telehealth was employed in 88.5% of 2020 visits but in none in 2018 or 2019. Despite the pandemic, more outpatients were seen in 2020 (n = 5,224) versus 2018 and 2019 (n = 5,099 per year). Using propensity matching, 4,541 telehealth visits in 2020 were compared with 4,541 in-person visits in 2018 and 2019, and groups were well matched. Mortality was similar for telehealth and in-person visits at both 30 days (0.8% vs 0.7%) and 90 days (2.9% vs 2.4%). Likewise, there was no excess in hospital encounters or need for intensive care with telehealth visits. CONCLUSIONS: A telehealth model for outpatients with heart failure allowed for distanced encounters without increases in subsequent acute care or mortality. As the pressures of the COVID-19 pandemic abate, these data suggest that telehealth outpatient visits in patients with heart failure can be safely incorporated into clinical practice. T he COVID-19 crisis created unprecedented challenges to health care delivery, leading to a dramatic transformation in the processes of outpatient care (1) . Furthermore, excess mortality has been reported in 2020 compared with in previous years, with only about two-thirds related to COVID-19 infections (2). The remaining excess mortality may be attributable to several factors, including a delay in patients seeking medical attention for non-COVID-19 illnesses. Given the imposition of stay-at-home orders and the hesitancy of patients to leave home in the initial stages of the pandemic, there was a need for an abrupt transition to outpatient telehealth visits that involve distanced real-time interaction between patients and providers using audio and/or video capabilities without direct physical interaction (3, 4) . This was encouraged by professional societies (5) and facilitated by Centers for Medicare and Medicaid Services and private payers by reimbursing telehealth visits at equal rates to in-person visits (3) . The rapid need to transition to telehealth services mandates an understanding of potential adverse outcomes associated with this transition (6) to help inform future telemedicine use in the heart failure (HF) population. HF is a particularly important disease for which to examine the impact of telehealth, as it is a chronic condition necessitating continual assessment of symptoms, health status, and medication adjustment (7) . Moreover, patients with HF are a particularly vulnerable population for complications related to COVID-19 infection, including critical illness and mortality (8) . At the start of the pandemic, our large Midwestern health care system transitioned to a predominantly telehealthbased model. This report describes the changes in delivering outpatient care for patients with HF during 2020 and compares outcomes to similar periods in 2018 and 2019. The Saint Luke's Health System is a large Midwestern Telehealth in Heart Failure During COVID-19 -2 0 2 1 : --significant differences in baseline characteristics between the matched cohorts ( Telehealth in Heart Failure During COVID-19 -2 0 2 1 : --- COVID-19 transforms health care through telemedicine: evidence from the field Medicare Telemedicine Health Care Provider Fact Sheet. Department of Health and Human Services gov/newsroom/fact-sheets/medicare-telemedicinehealth-care-provider-fact-sheet Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA Virtual visits for care of patients with heart failure in the era of COVID-19: a statement from the Heart Failure Society of America Use of telemedicine and virtual care for remote treatment in response to COVID-19 pandemic Clinical epidemiology of heart failure Prognostic impact of prior heart failure in patients hospitalized with COVID-19 Comparison of estimated rates of coronavirus disease 2019 (COVID-19) in border counties in Iowa without a stay-at-home order and border counties in Illinois with a stayat-home order Reductions in heart failure hospitalizations during the COVID-19 pandemic Virtual versus in-person visits and appointment no-show rates in heart failure care transitions